n(4)-octadecyl-1-arabinofuranosylcytosine has been researched along with sitagliptin phosphate in 1 studies
| Studies (n(4)-octadecyl-1-arabinofuranosylcytosine) | Trials (n(4)-octadecyl-1-arabinofuranosylcytosine) | Recent Studies (post-2010) (n(4)-octadecyl-1-arabinofuranosylcytosine) | Studies (sitagliptin phosphate) | Trials (sitagliptin phosphate) | Recent Studies (post-2010) (sitagliptin phosphate) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 1,715 | 471 | 1,390 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dzięgiel, P; Gomułkiewicz, A; Gziut, M; Merwid-Ląd, A; Nowak, B; Piasecki, T; Pieśniewska, M; Sozański, T; Szeląg, A; Szuba, A; Trocha, M; Wiśniewski, J | 1 |
1 other study(ies) available for n(4)-octadecyl-1-arabinofuranosylcytosine and sitagliptin phosphate
| Article | Year |
|---|---|
The impact of sitagliptin, inhibitor of dipeptidyl peptidase-4 (DPP-4), on the ADMA-DDAH-NO pathway in ischemic and reperfused rat livers.
Topics: Amidohydrolases; Animals; Arginine; Cytarabine; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Ischemia; Liver; Nitric Oxide; Protein-Arginine N-Methyltransferases; Rats; Reperfusion Injury; Sitagliptin Phosphate | 2018 |